The latest people and business news includes ACRO appointments and awards for CROs and service providers.
People
Bracket, a clinical trial specialty services provider, has appointed J. Matthew Bond as Chief Financial Officer and as a member of the company's leadership team. Most recently, Bond co-founded and served as the CFO of Aptiv Solutions.
DZS Clinical Services, a global provider of clinical development and data analytic services, has selected George Harb, MD, as its new vice president of clinical and medical affairs.
Greenphire, a provider of payment technology for the clinical trials industry, appointed David Horsley as Senior Director of European Business Development. Horsley will be responsible for enhancing and extending Greenphire's continued presence in Europe.
Profil Institute for Clinical Research, a clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, announced Christian Weyer, MD, M.A.S., as its President and Chief Development Officer. Weyer was most recently President and CEO of Fate Therapeutics.
Advanced Clinical, a global CRO, functional outsourcing and strategic talent acquisition provider, has added Denise Kurowski, Senior Vice President, FSP, to its leadership team. Kurowski most recently was Executive Vice President for Strategic Staffing Solutions.
Medical Research Network (MRN), a global home healthcare provider for clinical trials, has expanded with new hires in the UK and US. At MRN's UK headquarters, Jo Carter and Sue Lafferty join as a Project Managers, Charlotte Geen and Eleni Katsis both join as Project Support Associates; Matimba Swana joins as Business Development Executive, Rebecca Veall as Vendor and Contracts Associate, Harriet Wylie as Analyst and Fraser Wylie as Proposals and Contracts Associate.
In MRN's Chicago office, new hires include Jennifer Kilgore Project Manager, Saketh Gudipati, Project Support Associate and Leigh Schnake, Executive Assistant.
Decision Driver Analytics, a provider of product life cycle value analysis and health economic insight for drug and medical device developers, has announced the appointment of Heather Vecchiolla as vice president of business development and Madeline C. Rhoton as health economist. Most recently, Vecchiolla was the senior director of business development at ICON’s Commercialization and Outcomes group. Rhoton is a graduate of Duke University’s public policy analysis program who previously held an internship position at DDA.
Eurofins Bioanalytical Services, part of the broad-service Eurofins Pharma Services Group and a provider of bioanalytical testing to the biopharmaceutical, announced that Vimal Patel has joined the company as Scientific Director for large molecule bioanalysis based at the company's St Charles, MO facility. Patel was most recently with ICON as the Director of Business Development for bioanalytical sciences.
The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected David Simmons (below), Chairman and CEO of PPD as its 2016 Chairman, and John Hubbard, President and CEO of BioClinica, as Vice Chairman.
Business News
PRA Health Sciences relocated to a new office in Singapore to support its expanded operations in the region. The move will allow PRA to consolidate its workforce and be strategically located near many of its clients in the area.
OmniComm, a provider of clinical data management technology, announced its TrialOne eSource and site automation solution for early phase clinical sites has been deployed in early phase clinics that account for over 1,100 beds, 1,500 users and over 470 clinical studies within one year.
ERT, a cloud platform solutions provider of patient-centric data collection and intelligence solutions, is donating approximately 1,200 tablet computers to 21 Pittsburgh-based charitable organizations, including the Best of Batch Foundation, the Citizen Science Lab, and the Light of Life Rescue Mission.
Recognition
US Oncology Research awarded Donald Richards, MD, PhD, and Sharon Wilks, MD, FACP both with Texas Oncology the Highest Accruing Investigators Award. A complete list of members honored for their contributions to clinical research can be found here.
The Organization for Professionals in Regulatory Affairs (TOPRA) awarded Quintiles’ Global Regulatory Affairs its ‘Support Award,’ which recognizes the company’s high-quality regulatory science, strategy and operational support for a very challenging indication area.
IDG’s Computerworld named Xavier Flinois, President, PAREXEL Informatics, a 2016 Premier 100 Technology Leaders honoree. Flinois leads a global team of more than 2,500 technology professionals, including corporate IT and PAREXEL Informatics. The Premier 100 spotlights 100 leaders in technology and business for their exceptional technology leadership and innovative approaches to business challenges.
SCORR Marketing, a global full-service marketing and communications firm, recently received awards from the Public Relations Society of America (Nebraska) and eHealthcare Leadership Awards. SCORR received the Best of Show honor for its Camargo Pharmaceutical Services rebrand campaign, as well as an Award of Excellence and an Award of Merit for its Theorem Clinical Research (now Chiltern) rebrand campaign, respectively.
The Association of Clinical Research Professionals (ACRP) raised awareness of clinical trials and recognized the accomplishments of clinical research professionals in a special USA Today supplement that ran December 18-20 in major markets across the United States.
ERT, a cloud platform solutions provider of patient-centric data collection and intelligence solutions, has been named one of the 2015 20 Most Promising Data Integration Solution Providers by CIO Review based on ERT’s Insights Cloud - a new paradigm in clinical technology that provides sponsors and CROs with comprehensive insight into the risk and performance of clinical trials.
How Digital Technology and Remote Assessment Strategies Can Aid Clinical Trial Research
July 24th 2020While there's been hopeful news on treatments and vaccines, sponsors should plan to discuss necessary strategies and contingencies at the outset of new studies or re-opening of halted studies during the COVID-19 pandemic.